Mounjaro®
Starting from £179.99/mo
Start journey Learn moreCramps on Mounjaro are one of the more common muscular and gastrointestinal complaints people raise in the first weeks of treatment. They can affect the stomach, legs, or — less commonly — elsewhere, and they tend to cluster around dose increases rather than running at a constant level. Most settle within days as your body adjusts; some need a practical fix; a small number are a signal to get medical advice. Here is how to tell which is which, and what actually helps.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide (the medicine inside Mounjaro) acts on two gut-hormone receptors, GIP and GLP-1, and one of its effects is slowing the rate at which food leaves the stomach. That slowing is part of why appetite falls so reliably. It also means your digestive system is doing more work for longer, and the result for many people is cramping, bloating, or a griping sensation that can feel a bit like trapped wind.
The pattern is instructive: stomach cramps on Mounjaro typically arrive a few hours after eating, often worsen if you have eaten too quickly or chosen a large, fatty meal, and tend to be most noticeable in the first week or two at any given dose. When the dose increases, the pattern often repeats at a lower intensity than it did when you first started, your gut has learned some of what is coming, even if it is not fully prepared for a higher level of activity.
Practical things that genuinely help: smaller portions eaten slowly, reducing high-fat or very fibrous foods during the adjustment window, and staying hydrated. The full clinical picture of tirzepatide explains the mechanism in more detail if you want the background.
A question our prescribers hear most weeks goes something like: "I was not expecting leg cramps) is that really Mounjaro?" The honest answer is that leg cramps are not listed as a primary direct side effect, but they are a plausible downstream consequence of the changes treatment brings.
When nausea or reduced appetite leads to lower fluid and food intake, electrolyte levels (particularly potassium, magnesium and sodium) can dip. Muscles are sensitive to those shifts, and cramping, especially overnight in the calves or feet, is a classic result. If your diet has narrowed significantly on treatment, that matters too: protein and micronutrient intake can fall below what muscles need to recover from normal daily activity.
The practical priorities here are consistent fluid intake throughout the day, not just when thirsty, and checking that meals still contain adequate protein and a variety of vegetables even if portions are smaller. Leg cramps while on Mounjaro deserve their own look if this is your main concern, including what the clinical evidence actually says about frequency and what nutritional adjustments tend to help.
One note worth making: if you are also experiencing period-related cramping and are unsure whether Mounjaro is making it worse, the picture for Mounjaro and period cramps is genuinely distinct and covered separately.
Most cramps on Mounjaro are uncomfortable rather than dangerous. But there are specific patterns that should prompt you to seek same-day medical help rather than wait and see.
Severe, persistent stomach pain that reaches into your back (with or without vomiting) is the one to act on immediately. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines highlighting acute pancreatitis as an infrequent but potentially serious side effect; the symptom profile is exactly that: a deep, relentless abdominal pain that differs in character from the usual cramping and does not ease with position changes or passing wind.
Signs of significant dehydration from repeated vomiting or diarrhoea (dizziness on standing, very dark urine, inability to keep fluids down) also need prompt attention, not because they are common but because dehydration can affect kidney function quickly. Gallbladder discomfort (pain in the upper right abdomen, particularly after eating fatty food) is another pattern worth raising with a doctor rather than managing alone.
For cramping that is garden-variety GI discomfort, a read of what the NHS tirzepatide medicines page covers under side effects is a useful cross-check. If something does not match the typical picture, report it through the MHRA Yellow Card scheme and speak to your prescriber.
The decision about whether cramps are something to manage through lifestyle changes, something to keep an eye on, or a reason to pause or adjust treatment is a clinical one. It depends on how severe the cramps are, how long they have been present, whether they are affecting your ability to eat and drink normally, and whether there are any other symptoms alongside them.
Some people find that stomach cramping through a Mounjaro cycle follows a predictable pattern they can work around with timing adjustments and food choices. Others find that a particular dose level consistently causes cramping that outweighs the benefit at that level, and their prescriber holds them on a lower dose a little longer. Neither of those is a failure, titration exists precisely to find the dose your system handles well.
Mounjaro is a prescription-only medicine, and any decision to change, pause, or continue treatment following troublesome side effects should involve your prescriber rather than being made alone. If you are weighing up treatment options more broadly, the free consultation at nume is reviewed the same day by a GPhC-registered prescriber, a real clinician reads your answers, not an automated shortlist. For context on how treatment costs are structured, the cost of Mounjaro in the UK page covers what legitimate pricing looks like and what a transparent all-inclusive price actually contains.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.